VANCOUVER, BC / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company focused on developing therapeutics for rare and underserved ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. ("Lobe Sciences" ...

Biomaterials engineered to restore, replace, or augment damaged tissues are gaining momentum—and at the core are Regenerative ...

The global cell analyzer market is projected to grow at a CAGR of 8% from 2025 to 2030, driven by the rising prevalence of ...

The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of ...

The biopharmaceutical process analytical technology market is projected to grow at a CAGR of ~16% over the forecast ...

The global AI in ultrasound imaging market is set to witness a growth rate of 22% in the next 5 years. Growing adoption of AI ...

In recent years, the global health and wellness industry has seen an unprecedented evolution—not only in mainstream personal ...

Netsmart ranks as top EHR software in 2025's Top HIT Vendor for Inpatient Behavioral Health Systems WASHINGTON, D.C., WASHINGTON, D.C. / ACCESS Newswire / July 28, 2025 / Psychiatric hospitals and ...

GOTHENBURG, SWEDEN / ACCESS Newswire / July 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have ...

Capital IncreaseAbivax Announces Closing of $747.5 Million Public Offering 28.07.2025 / 22:15 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax Announces Closing of ...

This acquisition expands neurocare’s clinic network to 11 locations in the Netherlands and marks a key step into care focused on pregnancy, early parenthood, and family wellbeing. NIJMEGEN, ...